Bargman Joanne M
Medicine/Nephrology, University Health Network, Toronto, Ontario, Canada; and Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Clin J Am Soc Nephrol. 2015 Jun 5;10(6):1072-7. doi: 10.2215/CJN.12621214. Epub 2015 Mar 11.
There is no shortage of studies and registry data examining outcomes of patients on dialysis and those with a renal transplant. However, recently, there has been a greater focus on the events leading up to the institution of kidney replacement therapy. Associative data suggest that early and consistent predialysis care leads to better outcomes, including greater take-on to home-based therapy, diminished use of tunneled venous hemodialysis catheters, and improved early and even late survival. What transpires during predialysis visits is also important. Simple dissemination of facts to the unprepared patient is unlikely to be effective in moving the patient and family along in the process of the series of choices that have to be made around therapy. A more flexible and circumspect approach is needed, including recognizing when the patient is or is not ready for change. There seems to be no optimal timing of dialysis start that can be applied to the ESRD population as a whole, although the pendulum seems to be swinging back toward symptom-based rather than eGFR-based starts.
关于透析患者和肾移植患者的研究及登记数据并不匮乏。然而,最近人们更加关注肾脏替代治疗开始前的相关事件。关联数据表明,早期且持续的透析前护理可带来更好的结果,包括更多患者接受居家治疗、减少隧道式静脉血液透析导管的使用,以及改善早期甚至晚期生存率。透析前访视期间发生的事情也很重要。简单地向毫无准备的患者传达信息,不太可能有效地推动患者及其家属在围绕治疗必须做出的一系列选择过程中前进。需要一种更灵活、审慎的方法,包括认识到患者何时准备好或未准备好做出改变。虽然目前的趋势似乎正从基于估算肾小球滤过率(eGFR)开始透析转向基于症状开始透析,但似乎不存在适用于整个终末期肾病(ESRD)人群的最佳透析起始时机。